High-Dose Chemotherapy with Bendamustin and Melphalan Improves the Rate of Complete Remission in Myeloma Patients in First Remission Compared to Standard Melphalan Alone

被引：0
|
作者：
Farag, Sarah
Bacher, Ulrike
Legros, Myriam
Betticher, Daniel
Luthi, Jean-Marc
Egger, Thomas
Zander, Thilo
Jeker, Barbara
Pabst, Thomas
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141545
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] MULTIPLE-MYELOMA - COMPLETE REMISSION WITH HIGH-DOSE MELPHALAN CHEMOTHERAPY
    RICHARDS, F
    COLEMAN, M
    COOPER, MR
    BALLARD, WP
    CANCER INVESTIGATION, 1985, 3 (01) : 15 - 21
  • [2] High-dose melphalan in patients with multiple myeloma
    Moreau, P
    Le Bonniec, M
    Harousseau, JL
    BULLETIN DU CANCER, 1999, 86 (03) : 283 - 288
  • [3] High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission
    J Mehta
    R Powles
    B Sirohi
    J Treleaven
    S Kulkarni
    S Singhal
    Bone Marrow Transplantation, 2004, 33 : 1107 - 1114
  • [4] High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission
    Mehta, J
    Powles, R
    Sirohi, B
    Treleaven, J
    Kulkarni, S
    Singhal, S
    BONE MARROW TRANSPLANTATION, 2004, 33 (11) : 1107 - 1114
  • [5] Variation in melphalan dosing in myeloma patients undergoing high-dose chemotherapy and autotransplantation
    Mehta, J.
    Carson, K. R.
    Trifilio, S.
    Vickrey, E.
    Allen, S.
    Singhal, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Achievement of Complete Remission After High-Dose Melphalan and Autologous Stem Cell Transplantation Is the Only Important Prognostic Factor in Patients with Multiple Myeloma
    Shin, Seunghwan
    Kim, Jeong-A
    Lee, Bohee
    Min, Chang Ki
    Kwak, Jae-Yong
    Yhim, Ho-Young
    BLOOD, 2011, 118 (21) : 882 - 883
  • [7] Outpatient high-dose melphalan in multiple myeloma patients
    Kassar, Mohamad
    Medoff, Erin
    Seropian, Stuart
    Cooper, Dennis L.
    TRANSFUSION, 2007, 47 (01) : 115 - 119
  • [8] Intensive treatment with high-dose melphalan as initial therapy in newly-diagnosed patients with multiple myeloma: key to attain rapid complete remission (CR)
    Powles, R
    Sirohi, B
    Goyal, S
    Treleaven, J
    Sankpal, S
    Lloyd, C
    Rudin, C
    Rao, S
    Kulkarni, S
    BONE MARROW TRANSPLANTATION, 2002, 29 : S97 - S98
  • [9] Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma
    Gillich, Cedric
    Akhoundova, Dilara
    Hayoz, Michael
    Aebi, Yolanda
    Largiader, Carlo R.
    Seipel, Katja
    Daskalakis, Michael
    Bacher, Ulrike
    Pabst, Thomas
    CANCERS, 2023, 15 (10)
  • [10] High-dose melphalan chemotherapy with autologous stem cell transplantation in 65 patients with al amyloidosis: Organ progression can be delayed in patients reaching complete remission
    Schonland, S. O.
    Dengler, J. B.
    Hundemer, M.
    Bochtler, T.
    Singer, R.
    Hund, E.
    Beimler, J.
    Zeier, M.
    Kristen, A. V.
    Dengler, T. J.
    Ho, A. D.
    Goldschmidt, H.
    Hegenbart, U.
    XITH INTERNATIONAL SYMPOSIUM ON AMYLOIDOSIS, 2008, : 298 - +
12345